- Record: found
- Abstract: found
- Article: not found
Fungal infection in patients with end-stage liver disease: low frequency or low index of suspicion.
Elham A Hassan
1 ,
Abeer S Abd El-Rehim
2 ,
Sahar M Hassany
2 ,
Asmaa O Ahmed
3 ,
Nahla M Elsherbiny
4 ,
Mona H Mohammed
4
Jun 2014
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
End-stage liver disease (ESLD) is associated with dysregulation of the immune system and increased susceptibility to infections. Although invasive fungal infection (IFI) is a growing public health problem, studies of IFI in ESLD are lacking. The aims of this study were to screen for IFI in ESLD and to assess risk factors and serum interleukin 17 (IL-17) as a marker of the cellular immune response.